首页 > 最新文献

Journal of Hand and Microsurgery最新文献

英文 中文
Ulnar Styloid Fracture Accompanying Distal Radius Fracture Does Not Affect Hand Function, but What About Hand Dexterity? 伴有桡骨远端骨折的尺骨韧带骨折不会影响手部功能,但手部灵活性如何?
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2021-01-07 DOI: 10.1055/s-0040-1721564
Hande Usta, Umut Eraslan, Merve Sarıipek, Ali Kitis

Introduction  Hand dexterity is not addressed in patients with distal radius fracture (DRF) accompanied with ulnar styloid fracture (USF) in literature. This study aimed to determine whether an associated USF following a DRF has any effect on hand dexterity. Materials and Methods  Patients diagnosed with DRF were included in the study and were divided into two groups according to the USF presence (USF group and non-USF group). Pain, range of motion, Quick-DASH (Quick-Disabilities of the Arm, Shoulder, and Hand), handgrip and pinch strength, Purdue Pegboard test, and Jebsen Taylor Hand Function test were measured in the sixth month. Results  A total of 125 patients, 68 females (54.4%) and 57 males (45.6%) were included in the study. The mean age of the patients was 47.15 ± 13.41 (18-65) years. There were 60 patients (48%) in the USF group and 65 patients (52%) in the non-USF group. No significant difference was found in pain, range of motion, Quick-DASH and handgrip and pinch strength between the groups ( p > 0.05). The hand dexterity tests showed no statistically significant difference between the groups in the sixth month ( p > 0.05). Discussion  Hand function can be determined more accurately by assessing hand dexterity. In this study, it is emphasized that concomitant USF does not lead to poorer hand dexterity.

导言:文献中未提及桡骨远端骨折(DRF)伴尺侧腕骨骨折(USF)患者的手部灵活性。本研究旨在确定桡骨远端骨折(DRF)后伴有尺骨腕骨骨折(USF)是否会影响手部灵活性。材料与方法 研究纳入了确诊为 DRF 的患者,并根据是否存在 USF 将其分为两组(USF 组和非 USF 组)。在第 6 个月测量疼痛、活动范围、Quick-DASH(手臂、肩部和手部快速残疾)、手握力和捏力、Purdue Pegboard 测试和 Jebsen Taylor 手部功能测试。结果 共有 125 名患者参加了研究,其中女性 68 名(占 54.4%),男性 57 名(占 45.6%)。患者的平均年龄为 47.15 ± 13.41(18-65)岁。USF 组有 60 名患者(48%),非 USF 组有 65 名患者(52%)。两组患者在疼痛、活动范围、Quick-DASH、握力和夹力方面均无明显差异(P > 0.05)。第六个月的手部灵活性测试表明,两组间的差异无统计学意义(P > 0.05)。讨论 通过评估手的灵活性可以更准确地确定手的功能。本研究强调,同时使用 USF 不会导致手部灵活性变差。
{"title":"Ulnar Styloid Fracture Accompanying Distal Radius Fracture Does Not Affect Hand Function, but What About Hand Dexterity?","authors":"Hande Usta, Umut Eraslan, Merve Sarıipek, Ali Kitis","doi":"10.1055/s-0040-1721564","DOIUrl":"10.1055/s-0040-1721564","url":null,"abstract":"<p><p><b>Introduction</b>  Hand dexterity is not addressed in patients with distal radius fracture (DRF) accompanied with ulnar styloid fracture (USF) in literature. This study aimed to determine whether an associated USF following a DRF has any effect on hand dexterity. <b>Materials and Methods</b>  Patients diagnosed with DRF were included in the study and were divided into two groups according to the USF presence (USF group and non-USF group). Pain, range of motion, Quick-DASH (Quick-Disabilities of the Arm, Shoulder, and Hand), handgrip and pinch strength, Purdue Pegboard test, and Jebsen Taylor Hand Function test were measured in the sixth month. <b>Results</b>  A total of 125 patients, 68 females (54.4%) and 57 males (45.6%) were included in the study. The mean age of the patients was 47.15 ± 13.41 (18-65) years. There were 60 patients (48%) in the USF group and 65 patients (52%) in the non-USF group. No significant difference was found in pain, range of motion, Quick-DASH and handgrip and pinch strength between the groups ( <i>p</i> > 0.05). The hand dexterity tests showed no statistically significant difference between the groups in the sixth month ( <i>p</i> > 0.05). <b>Discussion</b>  Hand function can be determined more accurately by assessing hand dexterity. In this study, it is emphasized that concomitant USF does not lead to poorer hand dexterity.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"143-149"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426051/pdf/10-1055-s-0040-1721564.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39408218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Replantation after Traumatic Amputation at the Distal Forearm: Rehabilitation Protocol and Outcomes. 小儿前臂远端外伤截肢后的再植:康复方案和结果。
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2020-04-13 DOI: 10.1055/s-0040-1703096
Nicholas C Oleck, Radhika Malhotra, Haripriya S Ayyala, Ramazi O Datiashvili

Major limb replantation is a formidable task, especially in the pediatric setting. While meticulous microsurgical technique is required in the operating room, the authors aim to highlight the importance of postoperative rehabilitation therapy for optimal function. We highlight the case of a 12-year-old boy who suffered complete traumatic amputation through the distal left forearm. The limb was successfully replanted with successful restoration of sensation and function with the aid of intensive postoperative occupational therapy. A multidisciplinary team is of paramount importance to maximize function of a replanted upper extremity.

大肢再植是一项艰巨的任务,尤其是在儿科环境中。在手术室里需要一丝不苟的显微外科技术,而作者的目的则是强调术后康复治疗对实现最佳功能的重要性。我们重点介绍了一个 12 岁男孩的病例,他因外伤导致左前臂远端完全截肢。在术后强化职业治疗的帮助下,他的肢体成功再植,并成功恢复了感觉和功能。多学科团队对于最大限度地恢复再植上肢的功能至关重要。
{"title":"Pediatric Replantation after Traumatic Amputation at the Distal Forearm: Rehabilitation Protocol and Outcomes.","authors":"Nicholas C Oleck, Radhika Malhotra, Haripriya S Ayyala, Ramazi O Datiashvili","doi":"10.1055/s-0040-1703096","DOIUrl":"10.1055/s-0040-1703096","url":null,"abstract":"<p><p>Major limb replantation is a formidable task, especially in the pediatric setting. While meticulous microsurgical technique is required in the operating room, the authors aim to highlight the importance of postoperative rehabilitation therapy for optimal function. We highlight the case of a 12-year-old boy who suffered complete traumatic amputation through the distal left forearm. The limb was successfully replanted with successful restoration of sensation and function with the aid of intensive postoperative occupational therapy. A multidisciplinary team is of paramount importance to maximize function of a replanted upper extremity.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"169-172"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426049/pdf/10-1055-s-0040-1703096.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39408226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptomatic Periungual Fibroma of the Hand. 有症状的手掌周围纤维瘤
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2020-04-13 DOI: 10.1055/s-0040-1709099
Camelia Qian Ying Tang, Audrey Qi Xin Chia, Sreedharan Sechachalam

Periungual fibromas are benign nodules commonly found on acral digital areas that are commonly associated with tuberous sclerosis. They vary in size and are challenging to treat, with a high recurrence rate. We present a case of a patient with a periungual fibroma, which by virtue of its size, was of functional concern. The intraoperative findings and their implications on the clinical outcome, together with a literature review on other treatment modalities, are also presented.

毛周纤维瘤是一种良性结节,常见于尖锐湿疣的数字部位,通常与结节性硬化症有关。纤维瘤大小不一,治疗难度大,复发率高。我们介绍了一例肩周纤维瘤患者的病例,该纤维瘤因其大小而引起功能性关注。我们还介绍了术中发现及其对临床结果的影响,以及有关其他治疗方法的文献综述。
{"title":"Symptomatic Periungual Fibroma of the Hand.","authors":"Camelia Qian Ying Tang, Audrey Qi Xin Chia, Sreedharan Sechachalam","doi":"10.1055/s-0040-1709099","DOIUrl":"10.1055/s-0040-1709099","url":null,"abstract":"<p><p>Periungual fibromas are benign nodules commonly found on acral digital areas that are commonly associated with tuberous sclerosis. They vary in size and are challenging to treat, with a high recurrence rate. We present a case of a patient with a periungual fibroma, which by virtue of its size, was of functional concern. The intraoperative findings and their implications on the clinical outcome, together with a literature review on other treatment modalities, are also presented.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"173-177"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426038/pdf/10-1055-s-0040-1709099.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39408155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tendon Rupture in a Patient with Tuberculosis of the Hand Misdiagnosed as a Recurrent Dorsal Wrist Ganglion. 一名手部结核病患者的肌腱断裂被误诊为复发性腕背神经节。
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2020-08-13 DOI: 10.1055/s-0040-1714928
Mohammad M Al-Qattan
{"title":"Tendon Rupture in a Patient with Tuberculosis of the Hand Misdiagnosed as a Recurrent Dorsal Wrist Ganglion.","authors":"Mohammad M Al-Qattan","doi":"10.1055/s-0040-1714928","DOIUrl":"10.1055/s-0040-1714928","url":null,"abstract":"","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"202-204"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426047/pdf/10-1055-s-0040-1714928.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39408161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Arterial Grafts Used for Microvascular Arterial Reconstruction. 用于微血管动脉重建的动脉移植物回顾。
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2020-09-17 DOI: 10.1055/s-0040-1716588
Dino Papes

Arterial grafts are sometimes used in microvascular reconstruction and their clinical benefit over standard venous grafts is unknown. To determine arterial graft utilization in clinical microvascular arterial reconstruction, a review of the literature was done. PubMed search resulted with 4,352 finds, and after screening for relevance, 11 articles reporting on 55 arterial grafts were analyzed. All reports were retrospective studies, case reports, and case series, with no randomized controlled trials. Two retrospective series reported better patency of arterial versus venous grafts in upper-limb revascularization for chronic occlusion, but the findings were highly biased. Better patency of arterial grafts did not lead to higher rate of clinical improvement. Antiplatelet and lipid-lowering agents seem to be underused in venous graft recipients and use of no-touch venous grafting has not been reported. Based on the available data, routine use of arterial grafts cannot be recommended. Studies that show better patency of arterial grafts in hand revascularization for chronic vascular insufficiency are retrospective and biased, so a randomized controlled trial is needed.

微血管重建中有时会使用动脉移植物,与标准静脉移植物相比,动脉移植物的临床益处尚不清楚。为了确定动脉移植物在临床微血管重建中的应用情况,我们对文献进行了回顾。通过 PubMed 搜索,共找到 4352 篇文章,经过相关性筛选,分析了 11 篇报道 55 例动脉移植物的文章。所有报告均为回顾性研究、病例报告和病例系列,没有随机对照试验。有两篇回顾性系列研究报告称,在慢性闭塞的上肢血管再通手术中,动脉移植物的通畅性优于静脉移植物,但研究结果存在很大偏差。动脉移植物更好的通畅性并没有带来更高的临床改善率。静脉移植物接受者似乎未充分使用抗血小板和降血脂药物,也未见使用无接触静脉移植物的报道。根据现有数据,不建议常规使用动脉移植物。显示动脉移植物在慢性血管功能不全的手部血管重建中具有更好的通畅性的研究都是回顾性的,且存在偏差,因此需要进行随机对照试验。
{"title":"A Review of Arterial Grafts Used for Microvascular Arterial Reconstruction.","authors":"Dino Papes","doi":"10.1055/s-0040-1716588","DOIUrl":"10.1055/s-0040-1716588","url":null,"abstract":"<p><p>Arterial grafts are sometimes used in microvascular reconstruction and their clinical benefit over standard venous grafts is unknown. To determine arterial graft utilization in clinical microvascular arterial reconstruction, a review of the literature was done. PubMed search resulted with 4,352 finds, and after screening for relevance, 11 articles reporting on 55 arterial grafts were analyzed. All reports were retrospective studies, case reports, and case series, with no randomized controlled trials. Two retrospective series reported better patency of arterial versus venous grafts in upper-limb revascularization for chronic occlusion, but the findings were highly biased. Better patency of arterial grafts did not lead to higher rate of clinical improvement. Antiplatelet and lipid-lowering agents seem to be underused in venous graft recipients and use of no-touch venous grafting has not been reported. Based on the available data, routine use of arterial grafts cannot be recommended. Studies that show better patency of arterial grafts in hand revascularization for chronic vascular insufficiency are retrospective and biased, so a randomized controlled trial is needed.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"181-184"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426075/pdf/10-1055-s-0040-1716588.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39408158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Needle Fasciotomy versus Collagenase Injection for Dupuytren's Contracture: A Systematic Review of Comparative Studies. 经皮针式筋膜切开术与胶原酶注射治疗杜普伊特伦挛缩症:比较研究的系统回顾。
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2020-12-31 DOI: 10.1055/s-0040-1721876
Takashi Hirase, Rishi Suresh, Michael O Cotton, Alex Han, Matthew B Burn, Joshua D Harris, Shari R Liberman

Introduction  The purpose of this study was to review and compare clinical outcomes between percutaneous needle fasciotomy (PNF) and collagenase Clostridium histolyticum (CCH) injection for the treatment of Dupuytren's contracture. Materials and Methods  A systematic review was performed including all level I-III evidence studies investigating the clinical outcomes of PNF and CCH injection in the treatment of Dupuytren's contracture. Results  Five studies (278 CCH patients, 225 PNF patients; 285 CCH fingers, 246 PNF fingers, 405 males, and 98 females) were analyzed. Two randomized studies were level I evidence, one randomized study was level II, and two nonrandomized studies were level III. Two studies analyzed a total of 205 patients, each demonstrating statistically superior outcomes in one outcome measure (contracture improvement and Michigan Hand Questionnaire (MHQ) satisfaction subscore) with PNF, while the remaining three studies demonstrated no significant differences in outcomes between the two techniques. Three studies reported a statistically higher rate of minor complications (local pain, edema, ecchymosis, lymphadenopathy, pruritis) with CCH, while the remaining two studies demonstrated no significant difference in complication rates. Conclusion  For the treatment of Dupuytren's contracture, there is some evidence that suggests superior clinical outcomes of PNF compared with CCH and a higher minor complication rate with CCH.

引言 本研究旨在回顾和比较经皮针头筋膜切开术(PNF)和胶原酶组织溶解梭菌(CCH)注射治疗杜普伊特伦挛缩症的临床疗效。材料与方法 进行了一项系统性综述,包括所有调查皮针筋膜切开术和组织溶解胶原酶梭菌(CCH)注射治疗杜普伊特伦挛缩症临床疗效的 I-III 级证据研究。结果 分析了五项研究(278 名 CCH 患者、225 名 PNF 患者;285 名 CCH 手指、246 名 PNF 手指、405 名男性和 98 名女性)。其中两项随机研究为一级证据,一项随机研究为二级证据,两项非随机研究为三级证据。两项研究共对 205 名患者进行了分析,每项研究都表明,PNF 在一项结果测量(挛缩改善和密歇根手部问卷调查 (MHQ) 满意度子分数)上具有统计学上的优势,而其余三项研究则表明,两种技术在结果上没有显著差异。三项研究报告称,CCH 的轻微并发症(局部疼痛、水肿、瘀斑、淋巴结肿大、瘙痒症)发生率较高,而其余两项研究显示并发症发生率无明显差异。结论 对于杜普伊特伦挛缩症的治疗,有证据表明 PNF 的临床疗效优于 CCH,而 CCH 的轻微并发症发生率更高。
{"title":"Percutaneous Needle Fasciotomy versus Collagenase Injection for Dupuytren's Contracture: A Systematic Review of Comparative Studies.","authors":"Takashi Hirase, Rishi Suresh, Michael O Cotton, Alex Han, Matthew B Burn, Joshua D Harris, Shari R Liberman","doi":"10.1055/s-0040-1721876","DOIUrl":"10.1055/s-0040-1721876","url":null,"abstract":"<p><p><b>Introduction</b>  The purpose of this study was to review and compare clinical outcomes between percutaneous needle fasciotomy (PNF) and collagenase <i>Clostridium histolyticum</i> (CCH) injection for the treatment of Dupuytren's contracture. <b>Materials and Methods</b>  A systematic review was performed including all level I-III evidence studies investigating the clinical outcomes of PNF and CCH injection in the treatment of Dupuytren's contracture. <b>Results</b>  Five studies (278 CCH patients, 225 PNF patients; 285 CCH fingers, 246 PNF fingers, 405 males, and 98 females) were analyzed. Two randomized studies were level I evidence, one randomized study was level II, and two nonrandomized studies were level III. Two studies analyzed a total of 205 patients, each demonstrating statistically superior outcomes in one outcome measure (contracture improvement and Michigan Hand Questionnaire (MHQ) satisfaction subscore) with PNF, while the remaining three studies demonstrated no significant differences in outcomes between the two techniques. Three studies reported a statistically higher rate of minor complications (local pain, edema, ecchymosis, lymphadenopathy, pruritis) with CCH, while the remaining two studies demonstrated no significant difference in complication rates. <b>Conclusion</b>  For the treatment of Dupuytren's contracture, there is some evidence that suggests superior clinical outcomes of PNF compared with CCH and a higher minor complication rate with CCH.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"150-156"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426042/pdf/10-1055-s-0040-1721876.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39408221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated with Reoperation after Pyrocarbon Proximal Interphalangeal Joint Arthroplasty for the Arthritic Joint: A Retrospective Cohort Study. 与关节炎近端指间关节置换术后再次手术相关的因素:一项回顾性队列研究
IF 0.3 Q4 SURGERY Pub Date : 2021-07-01 Epub Date: 2020-04-09 DOI: 10.1055/s-0040-1709088
Bo J W Notermans, Jonathan Lans, Ryan P Ponton, Jesse B Jupiter, Neal C Chen

Introduction  The rate of reoperation after pyrocarbon proximal interphalangeal (PIP) joint arthroplasty ranges from 5.9 to 37% and complications such as radiographic loosening, deformity, dislocation, and stiffness are common. Because of the limited amount of knowledge around these problems, we evaluated factors associated with reoperation after pyrocarbon PIP arthroplasty. Materials and Methods  We retrospectively included all adult patients that underwent primary PIP pyrocarbon implant arthroplasty between 2002 and 2016 at one institutional system. A total of 45 patients, with a mean age of 55 (standard deviation: 14), underwent 66 PIP arthroplasties. To address for within individual correlations, we only included fingers treated at patients' initial surgery ( n = 54) in our statistical analysis. These patients were predominantly diagnosed with noninflammatory arthritis 73% ( n = 33). Arthroplasty was performed upon 10 index, 22 middle, 20 ring, and 2 small fingers. Results  The reoperation rate after pyrocarbon PIP arthroplasty was 30% over a median follow-up of 25 months (interquartile range: 8.7-54). Indications for reoperation consisted of subluxation ( n = 6), stiffness ( n = 5), swan-neck deformity ( n = 3), and soft tissue complications ( n = 2). Younger age ( p = 0.025), male sex ( p = 0.017), and noninflammatory arthritis ( p = 0.038) were associated with a higher reoperation rate. Conclusion  In this study, our reoperation rate after pyrocarbon PIP arthroplasty was 30%. This study suggested that younger patients, males, and patients with noninflammatory arthritis are at higher risk of reoperation. We recommend considering these factors when selecting candidates for pyrocarbon arthroplasty. Future studies should focus on prospectively researching these factors in comparison with other implants.

导言:热碳近端指间关节(PIP)关节成形术后的再手术率从 5.9% 到 37% 不等,放射学松动、畸形、脱位和僵硬等并发症很常见。由于对这些问题的了解有限,我们对焦碳PIP关节置换术后再次手术的相关因素进行了评估。材料和方法 我们回顾性地纳入了 2002 年至 2016 年间在一家机构系统内接受过初级 PIP 热碳植入关节置换术的所有成年患者。共有 45 名患者接受了 66 次 PIP 关节置换术,平均年龄为 55 岁(标准差:14 岁)。为了解决个体内部的相关性问题,我们仅将患者初次手术时接受治疗的手指(n = 54)纳入统计分析。这些患者主要被诊断为非炎症性关节炎,占 73% (33 人)。10 个食指、22 个中指、20 个无名指和 2 个小指接受了关节置换术。结果 在25个月的中位随访期间,热碳PIP关节置换术后的再手术率为30%(四分位间范围:8.7-54)。再手术指征包括半脱位(6 例)、僵硬(5 例)、天鹅颈畸形(3 例)和软组织并发症(2 例)。年轻(P = 0.025)、男性(P = 0.017)和非炎症性关节炎(P = 0.038)与较高的再手术率有关。结论 在本研究中,我们的热碳PIP关节置换术后再手术率为30%。这项研究表明,年轻患者、男性和患有非炎症性关节炎的患者再次手术的风险较高。我们建议在选择接受热碳化关节置换术的患者时考虑这些因素。未来的研究应侧重于将这些因素与其他植入物进行前瞻性比较研究。
{"title":"Factors Associated with Reoperation after Pyrocarbon Proximal Interphalangeal Joint Arthroplasty for the Arthritic Joint: A Retrospective Cohort Study.","authors":"Bo J W Notermans, Jonathan Lans, Ryan P Ponton, Jesse B Jupiter, Neal C Chen","doi":"10.1055/s-0040-1709088","DOIUrl":"10.1055/s-0040-1709088","url":null,"abstract":"<p><p><b>Introduction</b>  The rate of reoperation after pyrocarbon proximal interphalangeal (PIP) joint arthroplasty ranges from 5.9 to 37% and complications such as radiographic loosening, deformity, dislocation, and stiffness are common. Because of the limited amount of knowledge around these problems, we evaluated factors associated with reoperation after pyrocarbon PIP arthroplasty. <b>Materials and Methods</b>  We retrospectively included all adult patients that underwent primary PIP pyrocarbon implant arthroplasty between 2002 and 2016 at one institutional system. A total of 45 patients, with a mean age of 55 (standard deviation: 14), underwent 66 PIP arthroplasties. To address for within individual correlations, we only included fingers treated at patients' initial surgery ( <i>n</i> = 54) in our statistical analysis. These patients were predominantly diagnosed with noninflammatory arthritis 73% ( <i>n</i> = 33). Arthroplasty was performed upon 10 index, 22 middle, 20 ring, and 2 small fingers. <b>Results</b>  The reoperation rate after pyrocarbon PIP arthroplasty was 30% over a median follow-up of 25 months (interquartile range: 8.7-54). Indications for reoperation consisted of subluxation ( <i>n</i> = 6), stiffness ( <i>n</i> = 5), swan-neck deformity ( <i>n</i> = 3), and soft tissue complications ( <i>n</i> = 2). Younger age ( <i>p</i> = 0.025), male sex ( <i>p</i> = 0.017), and noninflammatory arthritis ( <i>p</i> = 0.038) were associated with a higher reoperation rate. <b>Conclusion</b>  In this study, our reoperation rate after pyrocarbon PIP arthroplasty was 30%. This study suggested that younger patients, males, and patients with noninflammatory arthritis are at higher risk of reoperation. We recommend considering these factors when selecting candidates for pyrocarbon arthroplasty. Future studies should focus on prospectively researching these factors in comparison with other implants.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"13 3","pages":"132-137"},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440050/pdf/10-1055-s-0040-1709088.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39430704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Routine Antithrombotic-Adjusted Dose of Rivaroxaban and Nadroparin Calcium on Tendon Healing of Rats: An Experimental Study. 常规抗血栓调整剂量的利伐沙班和纳络肝素钙对大鼠肌腱愈合的影响:一项实验研究
IF 0.3 Q4 SURGERY Pub Date : 2021-06-29 eCollection Date: 2023-04-01 DOI: 10.1055/s-0041-1729468
Suleyman Altun, Mehmet Sukru Sahin, Gokhan Çakmak, Kemal Gokkus, Aysen Terzi

Introduction  Achilles tendon injury necessitates thromboembolism prophylaxis after repair. This study aimed to investigate the effects of antithrombotic-adjusted prophylactic doses of nadroparin calcium and rivaroxaban on Achilles tendon healing. Materials and Methods  Twenty-four young adult male Wistar Albino type rats were randomly divided into three groups. All rats underwent a full-thickness surgical incision of the Achilles tendon, followed by primary repair. After the procedure, group 1 was determined as the control group and received no medication. Group 2 received 2.03 mg/kg rivaroxaban daily via gastric lavage once daily, and group 3 was given subcutaneous 114 IU AXa nadroparin calcium once daily for 28 days. After euthanization, the degrees of inflammation, neovascularization, fibroblastic activity, and collagen fiber sequencing were examined and scored for histopathological evaluation. The Statistical Package for Social Science (SPSS) version 21.0 for Windows software (SPSS, Inc., Chicago, Illinois, United States) was used for all statistical analyses. The number of inflammatory cells, capillary vessels, and fibroblasts, which met the parametric tests' assumptions, were compared between three independent groups by one-way analysis of variance. The significance level was set at p- value < 0.05. Results  Histological examination of the group 1 sample showed the presence of inflammatory cells, an increase in the number of fibroblasts, and sequencing of collagen fibers scattered. The presence of inflammatory cells, remarkable increases in the number of fibroblasts, the presence of mature collagen fibers, and regular sequencing of collagen fibers regular were shown in groups 2 and 3. There were statistically significant differences between the groups regarding the number of inflammatory cells and fibroblasts. In group 2, the number of inflammatory cells was lower than in groups 1 and 3. Elsewhere, the number of fibroblasts was higher in group 1 compared than in groups 2 and 3. Conclusion  Both rivaroxaban and nadroparin calcium in their daily dosage have a beneficial effect on Achilles tendon healing.

引言 跟腱损伤需要在修复后进行血栓栓塞预防。本研究旨在探讨抗血栓调整后的纳多肝素钙和利伐沙班预防剂量对跟腱愈合的影响。材料与方法 24 只年轻的成年雄性 Wistar Albino 型大鼠被随机分为三组。所有大鼠均接受跟腱全厚手术切口,然后进行初级修复。手术后,第 1 组为对照组,不接受任何药物治疗。第2组每天一次通过洗胃接受2.03 mg/kg 利伐沙班,第3组每天一次皮下注射114 IU AXa 纳多肝素钙,共28天。安乐死后,检查炎症程度、新生血管、成纤维细胞活性和胶原纤维排序,并进行组织病理学评估评分。所有统计分析均使用社会科学统计软件包(SPSS)21.0 Windows 版软件(SPSS, Inc.通过单因素方差分析比较三个独立组之间符合参数检验假设的炎症细胞、毛细血管和成纤维细胞的数量。结果 第 1 组样本的组织学检查显示存在炎症细胞,成纤维细胞数量增加,胶原纤维散布有序。第 2 组和第 3 组样本显示存在炎性细胞、成纤维细胞数量显著增加、存在成熟的胶原纤维、胶原纤维排序规则。在炎症细胞和成纤维细胞的数量上,各组之间存在明显的统计学差异。第 2 组的炎症细胞数量低于第 1 组和第 3 组。在其他地方,第 1 组的成纤维细胞数量高于第 2 组和第 3 组。结论 每天服用利伐沙班和纳多肝素钙对跟腱的愈合都有好处。
{"title":"Effects of Routine Antithrombotic-Adjusted Dose of Rivaroxaban and Nadroparin Calcium on Tendon Healing of Rats: An Experimental Study.","authors":"Suleyman Altun, Mehmet Sukru Sahin, Gokhan Çakmak, Kemal Gokkus, Aysen Terzi","doi":"10.1055/s-0041-1729468","DOIUrl":"10.1055/s-0041-1729468","url":null,"abstract":"<p><p><b>Introduction</b>  Achilles tendon injury necessitates thromboembolism prophylaxis after repair. This study aimed to investigate the effects of antithrombotic-adjusted prophylactic doses of nadroparin calcium and rivaroxaban on Achilles tendon healing. <b>Materials and Methods</b>  Twenty-four young adult male <i>Wistar Albino type rats</i> were randomly divided into three groups. All rats underwent a full-thickness surgical incision of the Achilles tendon, followed by primary repair. After the procedure, group 1 was determined as the control group and received no medication. Group 2 received 2.03 mg/kg rivaroxaban daily via gastric lavage once daily, and group 3 was given subcutaneous 114 IU AXa nadroparin calcium once daily for 28 days. After euthanization, the degrees of inflammation, neovascularization, fibroblastic activity, and collagen fiber sequencing were examined and scored for histopathological evaluation. The Statistical Package for Social Science (SPSS) version 21.0 for Windows software (SPSS, Inc., Chicago, Illinois, United States) was used for all statistical analyses. The number of inflammatory cells, capillary vessels, and fibroblasts, which met the parametric tests' assumptions, were compared between three independent groups by one-way analysis of variance. The significance level was set at <i>p-</i> value < 0.05. <b>Results</b>  Histological examination of the group 1 sample showed the presence of inflammatory cells, an increase in the number of fibroblasts, and sequencing of collagen fibers scattered. The presence of inflammatory cells, remarkable increases in the number of fibroblasts, the presence of mature collagen fibers, and regular sequencing of collagen fibers regular were shown in groups 2 and 3. There were statistically significant differences between the groups regarding the number of inflammatory cells and fibroblasts. In group 2, the number of inflammatory cells was lower than in groups 1 and 3. Elsewhere, the number of fibroblasts was higher in group 1 compared than in groups 2 and 3. <b>Conclusion</b>  Both rivaroxaban and nadroparin calcium in their daily dosage have a beneficial effect on Achilles tendon healing.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"15 2","pages":"133-140"},"PeriodicalIF":0.3,"publicationDate":"2021-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/ce/10-1055-s-0041-1729468.PMC10070002.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9292686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reintervention, PROMs, and Factors Influencing PROMs Following Surgery for de Quervain's Tenosynovitis. 杜氏腱鞘炎手术后的再干预、PROMs 和影响 PROMs 的因素。
IF 0.3 Q4 SURGERY Pub Date : 2021-06-19 eCollection Date: 2023-06-01 DOI: 10.1055/s-0041-1731105
Meryam Zamri, Jonathan Lans, Kyle R Eberlin, Rohit Garg, Jesse B Jupiter, Neal C Chen

Objective  The aims of this study are to describe and identify the factors that influence patient reported outcomes following surgery of de Quervain's tenosynovitis. The secondary objective is to report the rate of reintervention following surgery of de Quervain's tenosynovitis. Patients and Methods  Outcomes using the numerical rating scale (NRS) for pain, Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH), Patient-Rated Wrist Evaluation (PRWE), the Patients Reported Outcome Measurement Information System Pain Interference (PROMIS PI), and a custom de Quervain's questionnaire were obtained. A multivariable linear regression analysis was performed to identify independent factors associated with patient-reported outcomes. Results  Seventy-six patients who underwent de Quervain's release participated. The average age was 52.8 years (95% confidence interval: 49.6-56.1) and median follow-up age was 7.0 years (interquartile range [IQR]: 4.3-12.0). Outcomes were: NRS of pain was 0 (IQR: 0.0-3.0), the median QuickDASH was 6.82 (IQR: 0.00-28.41), the median PRWE score was 4.0 (IQR: 0.00-18.50), and the median PROMIS PI score was 43.90 (IQR: 38.70-53.90). Eighteen (23.7%) of the patients reported pain with thumb activities, four of whom had a reintervention. Additionally, 21 (26.9%) patients reported decreased strength in the thumb compared to the contralateral side, of which two underwent a reintervention. In total, eight patients underwent reintervention of which seven had a second surgery and one had a cortisone injection. Conclusion  Roughly 1 in 20 patients following de Quervain's release undergoes reintervention. Patients with high PROMIS PI scores report poor surgical outcomes more frequently. Patients with high PROMIS PI scores report higher NRS pain scores ( p  < 0.05), higher QuickDASH scores ( p  < 0.05), and higher PRWE scores ( p  < 0.05). In practice, careful consideration of PROMIS PI scores and psychosocial factors are recommended before considering reintervention.

目的 本研究旨在描述和确定影响患者在接受杜氏腱鞘炎手术后报告结果的因素。次要目的是报告手术治疗杜氏腱鞘炎后的再干预率。患者和方法 使用疼痛数字评分量表(NRS)、手臂、肩部和手部快速残疾评分量表(QuickDASH)、患者评定腕部评估(PRWE)、患者报告结果测量信息系统疼痛干扰(PROMIS PI)和定制的杜氏腱鞘炎问卷调查结果。进行了多变量线性回归分析,以确定与患者报告结果相关的独立因素。结果 76 名患者接受了德-克万氏松解术。平均年龄为 52.8 岁(95% 置信区间:49.6-56.1),中位随访年龄为 7.0 岁(四分位数间距 [IQR]:4.3-12.0)。结果如下疼痛 NRS 为 0(IQR:0.0-3.0),QuickDASH 中位数为 6.82(IQR:0.00-28.41),PRWE 中位数为 4.0(IQR:0.00-18.50),PROMIS PI 中位数为 43.90(IQR:38.70-53.90)。有 18 名患者(23.7%)报告在拇指活动时感到疼痛,其中 4 人接受了再次干预。此外,21 名患者(26.9%)报告拇指力量比对侧减弱,其中两人接受了再次干预。共有八名患者接受了再次干预,其中七人进行了第二次手术,一人注射了可的松。结论 大约每 20 名德-克尔万氏松解术患者中就有 1 人接受再介入治疗。PROMIS PI评分高的患者更常出现手术效果不佳的情况。PROMIS PI评分高的患者NRS疼痛评分更高(p p p p
{"title":"Reintervention, PROMs, and Factors Influencing PROMs Following Surgery for de Quervain's Tenosynovitis.","authors":"Meryam Zamri, Jonathan Lans, Kyle R Eberlin, Rohit Garg, Jesse B Jupiter, Neal C Chen","doi":"10.1055/s-0041-1731105","DOIUrl":"10.1055/s-0041-1731105","url":null,"abstract":"<p><p><b>Objective</b>  The aims of this study are to describe and identify the factors that influence patient reported outcomes following surgery of de Quervain's tenosynovitis. The secondary objective is to report the rate of reintervention following surgery of de Quervain's tenosynovitis. <b>Patients and Methods</b>  Outcomes using the numerical rating scale (NRS) for pain, Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH), Patient-Rated Wrist Evaluation (PRWE), the Patients Reported Outcome Measurement Information System Pain Interference (PROMIS PI), and a custom de Quervain's questionnaire were obtained. A multivariable linear regression analysis was performed to identify independent factors associated with patient-reported outcomes. <b>Results</b>  Seventy-six patients who underwent de Quervain's release participated. The average age was 52.8 years (95% confidence interval: 49.6-56.1) and median follow-up age was 7.0 years (interquartile range [IQR]: 4.3-12.0). Outcomes were: NRS of pain was 0 (IQR: 0.0-3.0), the median QuickDASH was 6.82 (IQR: 0.00-28.41), the median PRWE score was 4.0 (IQR: 0.00-18.50), and the median PROMIS PI score was 43.90 (IQR: 38.70-53.90). Eighteen (23.7%) of the patients reported pain with thumb activities, four of whom had a reintervention. Additionally, 21 (26.9%) patients reported decreased strength in the thumb compared to the contralateral side, of which two underwent a reintervention. In total, eight patients underwent reintervention of which seven had a second surgery and one had a cortisone injection. <b>Conclusion</b>  Roughly 1 in 20 patients following de Quervain's release undergoes reintervention. Patients with high PROMIS PI scores report poor surgical outcomes more frequently. Patients with high PROMIS PI scores report higher NRS pain scores ( <i>p</i>  < 0.05), higher QuickDASH scores ( <i>p</i>  < 0.05), and higher PRWE scores ( <i>p</i>  < 0.05). In practice, careful consideration of PROMIS PI scores and psychosocial factors are recommended before considering reintervention.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"15 3","pages":"165-174"},"PeriodicalIF":0.3,"publicationDate":"2021-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306984/pdf/10-1055-s-0041-1731105.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9729628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Matching Kienböck's Treatment Options to Specific Features of Each Case. 将基恩伯克治疗方案与每个病例的具体特征相匹配。
IF 0.3 Q4 SURGERY Pub Date : 2021-06-19 eCollection Date: 2023-04-01 DOI: 10.1055/s-0041-1730888
Mark Henry, Forrest H Lundy, Giselle K Henry

Kienböck's disease is best understood as a continuous interaction between compromised perfusion and structural deterioration that transitions from an early phase to a late phase. Existing literature has failed to identify any one superior treatment for Kienböck's; many studies even demonstrate no advantage for surgery compared with the natural history. Surgical interventions for early and transitional Kienböck's are designed to preserve or reconstruct the lunate. However, in most studies, the only tool used to assess the lunate itself has been plain radiography that neither reveals critical architectural details (demonstrated by computed tomographic scan) nor the vascular status (demonstrated by magnetic resonance imaging). Most articles, therefore, do not adequately define the preoperative status of the lunate or its alteration through surgical intervention. Critical preoperative features that are best demonstrated by these advanced imaging studies have specific anatomic and physiologic relationships that better correspond with certain surgical interventions, which also pair better with specific patient characteristics. This review explains how to identify, analyze, and strategically match these variables with the treatment interventions available for Kienböck's patients through the early, transitional, and late phases of the disease.

基恩伯克病最好被理解为灌注受损和结构退化之间的持续互动,从早期阶段过渡到晚期阶段。现有文献未能发现任何一种治疗基恩伯克病的有效方法;许多研究甚至表明,与自然病史相比,手术治疗并无优势。针对早期和过渡期基恩伯克氏症的手术干预旨在保留或重建月骨。然而,在大多数研究中,用于评估月骨本身的唯一工具是普通X光片,既不能显示关键的建筑细节(通过计算机断层扫描显示),也不能显示血管状态(通过磁共振成像显示)。因此,大多数文章都没有充分定义月骨的术前状态或手术干预对其造成的改变。这些先进的成像研究最能体现术前的关键特征,它们具有特定的解剖和生理关系,能更好地配合某些手术干预,也能更好地配合特定患者的特征。本综述介绍了如何识别、分析这些变量,并将其与基恩伯克病患者在疾病早期、过渡阶段和晚期的治疗干预措施进行策略性匹配。
{"title":"Matching Kienböck's Treatment Options to Specific Features of Each Case.","authors":"Mark Henry, Forrest H Lundy, Giselle K Henry","doi":"10.1055/s-0041-1730888","DOIUrl":"10.1055/s-0041-1730888","url":null,"abstract":"<p><p>Kienböck's disease is best understood as a continuous interaction between compromised perfusion and structural deterioration that transitions from an early phase to a late phase. Existing literature has failed to identify any one superior treatment for Kienböck's; many studies even demonstrate no advantage for surgery compared with the natural history. Surgical interventions for early and transitional Kienböck's are designed to preserve or reconstruct the lunate. However, in most studies, the only tool used to assess the lunate itself has been plain radiography that neither reveals critical architectural details (demonstrated by computed tomographic scan) nor the vascular status (demonstrated by magnetic resonance imaging). Most articles, therefore, do not adequately define the preoperative status of the lunate or its alteration through surgical intervention. Critical preoperative features that are best demonstrated by these advanced imaging studies have specific anatomic and physiologic relationships that better correspond with certain surgical interventions, which also pair better with specific patient characteristics. This review explains how to identify, analyze, and strategically match these variables with the treatment interventions available for Kienböck's patients through the early, transitional, and late phases of the disease.</p>","PeriodicalId":45368,"journal":{"name":"Journal of Hand and Microsurgery","volume":"15 2","pages":"87-97"},"PeriodicalIF":0.3,"publicationDate":"2021-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/8b/10-1055-s-0041-1730888.PMC10070007.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9292687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Hand and Microsurgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1